Contraception

Contraception · ISSN (e) 1879-0518 · 135 papers in corpus
case-report 2026
doi:10.1016/j.contraception.2026.111435 ·PMID:41862114

This case explored a novel surgical method to fix levonorgestrel 52-mg intrauterine devices in patients with adenomyosis and uterine septum. The procedure is convenient and feasible, and successfully applied the technique in a 43-year-old p…

other 2025
doi:10.1016/j.contraception.2024.110719 ·PMID:39341444

OBJECTIVES: To describe contraceptive use for pregnancy prevention among transgender men and gender diverse (TGD) individuals assigned female or intersex at birth (AFIAB) and explore whether contraceptive use differs by testosterone use. S…

observational 2025
doi:10.1016/j.contraception.2024.110784 ·PMID:39701207

ObjectivesTo explore whether discussing contraceptive use with a healthcare provider is associated with current contraceptive use among transgender men and gender-diverse (TMGD) individuals.Study designIn 2019, we conducted a cross-sectiona…

observational 2025
doi:10.1016/j.contraception.2025.111046 ·PMID:40752815

OBJECTIVES: Evidence regarding risk for hysterectomy following treatment for benign gynecological conditions with a levonorgestrel-releasing intrauterine device (LNG-IUD) is limited. We assess whether race and ethnicity are associated with …

observational 2025
doi:10.1016/j.contraception.2025.111016 ·PMID:40669656

OBJECTIVE: We aimed to assess the effects of contraception with NuvaRing on ultrasound signs and symptoms of women with adenomyosis. STUDY DESIGN: We conducted a prospective self-controlled observational study on women with adenomyosis who…

observational 2023
doi:10.1016/j.contraception.2022.11.006 ·PMID:36476331

OBJECTIVES: Exogenous estrogen is associated with growth of hepatocellular adenomas (HCAs), although the influence of progestin-only agents is unknown. We therefore evaluated the association of progestin-only agents on HCA progression compa…

observational 2023
doi:10.1016/j.contraception.2023.110089 ·PMID:37331461

OBJECTIVES: To estimate the hazard of incident idiopathic intracranial hypertension, a potentially blinding condition, among women using levonorgestrel intrauterine devices (LNG-IUD) compared to copper IUD, as conflicting associations have …

other 2022
doi:10.1016/j.contraception.2022.03.021 ·PMID:35351446

OBJECTIVE: We aimed to qualitatively describe the contraceptive experiences of individuals with medical conditions and develop an explanatory model of contraceptive decision-making in this context. STUDY DESIGN: We conducted 41 interviews …

rct 2022
doi:10.1016/j.contraception.2022.04.002 ·PMID:35430238

OBJECTIVES: To describe ovulation inhibition and safety of daily oral ulipristal acetate (UPA) over 84 days. STUDY DESIGN: This multi-center phase 1 and/or 2 trial randomized participants to use oral ulipristal 10 mg or 5 mg daily or a 3 c…

observational 2022
doi:10.1016/j.contraception.2022.109920 ·PMID:36529241

OBJECTIVES: To monitor pregnancy occurrence and outcomes among Nexplanon users in the United States during standard clinical practice. STUDY DESIGN: The Nexplanon Observational Risk Assessment (NORA) study was a large prospective cohort st…

observational 2022
doi:10.1016/j.contraception.2022.08.006 ·PMID:36057322

OBJECTIVES: We collected real-world data on the safety and clinical outcomes of the levonorgestrel-releasing intrauterine system (LNG-IUS) for heavy menstrual bleeding and dysmenorrhea. STUDY DESIGN: This was a prospective, multicenter, si…

lab-animal 2021
doi:10.1016/j.contraception.2021.03.032 ·PMID:33894249

OBJECTIVES: To determine if PF-88, a reverse thermo-responsive polymer designed to create a gel at body temperature and liquefy at a lower temperature (21°C) can reversibly occlude the fallopian tubes in rabbits. STUDY DESIGN: Mature femal…

observational 2021
doi:10.1016/j.contraception.2021.10.015 ·PMID:34752776

OBJECTIVE: To compare the prevalence of clinical post-ablation tubal sterilization syndrome among women who underwent abdominal (i.e., peripartum or laparoscopic) vs hysteroscopic permanent contraception in addition to endometrial ablation.…

guideline 2021
doi:10.1016/j.contraception.2021.07.004 ·PMID:34273335

OBJECTIVE: To develop a minimum data set, known as a core outcome set, for future abortion randomized controlled trials. STUDY DESIGN: We extracted outcomes from quantitative and qualitative systematic reviews of abortion studies to assess…

other 2020
doi:10.1016/j.contraception.2019.10.001 ·PMID:31655066

OBJECTIVES: To determine if women with tubal patency experience more fluid loss compared to those with bilateral tubal occlusion following intrauterine instillation of fluid via a balloon catheter. STUDY DESIGN: In this prospective cohort …

other 2020
doi:10.1016/j.contraception.2020.04.010 ·PMID:32353358

BACKGROUND: Pelvic pain has been associated with Essure, a permanent contraceptive implant. Here we describe histopathologic findings in long-term Essure users with chronic pelvic pain. METHODS: We descriptively evaluated and compared hist…

other 2020
doi:10.1016/j.contraception.2020.07.093 ·PMID:32768397

OBJECTIVES: To characterize reasons for hormonal contraceptive (HC) use in 1,455 African-American women, aged 23-35 years. STUDY DESIGN: The community-based cohort members were recruited from the Detroit, Michigan area in 2010-2012. HC his…

qualitative 2019
doi:10.1016/j.contraception.2019.03.046 ·PMID:30980830

OBJECTIVE: To explore perspectives on family planning among young people who perceive they are infertile or will have difficulty carrying a pregnancy to term owing to medical conditions or procedures. METHODS: This exploratory analysis exa…

lab-animal 2018
doi:10.1016/j.contraception.2018.08.001 ·PMID:30114392

OBJECTIVE: To compare the effects of chlormadinone acetate (CMA), dienogest (DNG) and drospirenone (DRSP) on prostaglandin biosynthesis in a human endometrial explants model. STUDY DESIGN: Human endometrial explants obtained by aspiration …

other 2018
doi:10.1016/j.contraception.2018.02.008 ·PMID:29477633
observational 2017
doi:10.1016/j.contraception.2017.12.015 ·PMID:29288653

OBJECTIVES: The objectives were to compare the long-term outcomes, including hysterectomy, chronic pelvic pain (CPP) and abnormal uterine bleeding (AUB), in women post hysteroscopic sterilization (HS) and laparoscopic tubal ligation (TL) in…

other 2017
doi:10.1016/j.contraception.2016.12.009 ·PMID:28065833
other 2017
doi:10.1016/j.contraception.2017.07.169 ·PMID:28801054

OBJECTIVE: Following the 2016US presidential election, social media posts and news stories amplified concerns about the potential for reduced access to contraception under the incoming administration and urged women to seek long-acting reve…

observational 2016
doi:10.1016/j.contraception.2016.06.010 ·PMID:27343748

OBJECTIVES: The International Active Surveillance study "Safety of Contraceptives: Role of Estrogens" (INAS-SCORE) investigated the cardiovascular risks associated with the use of a combined oral contraceptive (COC) containing dienogest and…

meta-analysis 2016
doi:10.1016/j.contraception.2016.02.003 ·PMID:26874275

CONTEXT: Depot medroxyprogesterone acetate (DMPA), a progestogen-only contraceptive injectable, has traditionally been formulated as a crystalline suspension delivered intramuscularly (IM) at a dose of 150mg/1.0mL. A new, lower dose formula…